KALA (KALA BIO, Inc. Common Stock) Stock Analysis - Politician Trades

KALA BIO, Inc. Common Stock (KALA) is a publicly traded Healthcare sector company. As of May 21, 2026, KALA trades at $2.65 with a market cap of $50.38M and a P/E ratio of -0.82. KALA moved +4.35% today. Year to date, KALA is -91.40%; over the trailing twelve months it is -98.66%. Its 52-week range spans $2.52 to $1,030.00. Rallies surfaces KALA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded KALA stock?

Rallies tracks politician and congressional stock disclosures for KALA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

KALA Key Metrics

Key financial metrics for KALA
MetricValue
Price$2.65
Market Cap$50.38M
P/E Ratio-0.82
EPS$-3.31
Dividend Yield0.00%
52-Week High$1,030.00
52-Week Low$2.52
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$-26.98M
Gross Margin0.00%

Latest KALA News

Recent KALA Insider Trades

  • Iwicki Mark T sold 154.89K (~$125.46K) on Oct 23, 2025.
  • Reumuth Mary sold 967 (~$792.94) on Oct 23, 2025.
  • Reumuth Mary sold 32.23K (~$26.75K) on Oct 22, 2025.

KALA Analyst Consensus

KALA analyst coverage data. Average price target: $0.00.

Common questions about KALA

Which politicians traded KALA stock?
Rallies tracks politician and congressional stock disclosures for KALA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in KALA?
Yes. Rallies tracks politician and congressional stock disclosures for KALA, including reported purchases, sales, dates, owners, and trade amounts when available.
Is KALA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for KALA. It does not provide personalized investment advice.
KALA

KALA